Kolmar Korea : Interim Report on Business Performance (Fair Disclosure)
February 24, 2022 at 02:42 am EST
Share
Interim Report on Business Performance (Fair Disclosure)
※ The following are interim figures, and may be different from final data.
1. Details of business performance
in KRW mn, %
Category
Current period
Previous period
Changes over previous period (%)
Same period of last year
Changes over same period of last year (%)
(Q4 2021)
(Q3 2021)
(Q4 2020 )
Sales
Current
148,417
141,840
4.6
137,483
8.0
Cumulative
632,824
484,407
30.6
609,201
3.9
Operating income
Current
19,606
10,355
89.3
7,052
178.0
Cumulative
65,642
46,037
42.6
50,356
30.4
Net income from continuing operation before income tax
Current
11,798
14,799
-20.3
115,393
-89.8
Cumulative
61,817
50,020
23.6
153,201
-59.7
Net income
Current
10,491
11,218
-6.5
79,403
-86.8
Cumulative
48,406
37,915
27.7
120,834
-59.9
-
-
-
-
-
-
2. Details of information released
Information provider
Kolmar Korea Finance Team
Information recipients
Domestic and foreign investors
mass media organizations, etc.
Date & time of information released
To be provided ad hoc after this
disclosure
Title and place of event held
-
3. Contact points (department/phone number)
Kolmar Korea Finance Team
(02-515-5150)
4. Other matters to be factored into investment decisions
- The results above are based on the separate financial statements prepared
in accordance with Korean International Financial Reporting Standards (K-IFRS).
- The results above have not been fully audited by an external auditor, and are
subject to change in the course of the audit.
- The profits from the sale of the pharmaceutical division in 4Q 2020 are included
in the net income from continuing operation before income tax and the net income
in 4Q 2020.
※ Related disclosure
2022-02-21 Interim Report on Business Performance (Fair Disclosure)
Attachments
Original Link
Original Document
Permalink
Disclaimer
Korea Kolmar Holdings Co. Ltd. published this content on 24 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 February 2022 07:41:03 UTC.
Kolmar Holdings Co Ltd, formerly KOLMAR KOREA HOLDINGS CO., LTD., is a Korea-based holding company engaged in the manufacture and sale of food. The Company is engaged in the original development and design manufacturing (ODM) of cosmetics, original equipment manufacturing (OEM) of pharmaceuticals, leasing of real estates and others. In addition, the Company is engaged in the manufacture and sale of health foods and other products.